Results 91 to 100 of about 2,050 (152)

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates

open access: yes, 2018
The novel fluorocycline antibiotic eravacycline is in development for use in the treatment of serious infections caused by susceptible and multidrug-resistant (MDR) aerobic and anaerobic Gram-negative and Gram-positive pathogens.
Trudy H. Grossman   +5 more
core   +1 more source

Novel Tetracyclines Versus Alternative Antibiotics for Treating Acute Bacterial Infection: A Meta-Analysis of Randomized Controlled Trials

open access: yesAntibiotics, 2019
This meta-analysis assessed the efficacy and safety of novel tetracyclines for treating acute bacterial infections. Data from PubMed, Web of Science, EBSCO, Cochrane databases, Ovid Medline, and Embase databases were accessed until 11 July 2019.
Shao-Huan Lan   +6 more
doaj   +1 more source

Clinical Efficacy of Eravacycline in the Treatment of Pneumonia: A Multicenter Real World Study

open access: yesXiehe Yixue Zazhi
ObjectiveTo evaluate the efficacy and safety of eravacycline in the treatment of pulmonary infections based on real-world data.MethodsThis multicenter retrospective cohort study enrolled patients with pulmonary infections who received eravacycline ...
WANG Di   +7 more
doaj   +1 more source

The Efficacy and Safety of Eravacycline in the Treatment of Complicated Intra-Abdominal Infections: A Systemic Review and Meta-Analysis of Randomized Controlled Trials

open access: yes, 2019
This study aims to assess the clinical efficacy and safety of eravacycline for treating complicated intra-abdominal infection (cIAI) in adult patients.
Shao-Huan Lan   +4 more
core   +1 more source

Additional file 4 of Integrative analysis of outer membrane vesicles proteomics and whole-cell transcriptome analysis of eravacycline induced Acinetobacter baumannii strains

open access: yes, 2020
Additional file 4.LC/MS–MS proteomic analysis of OMVs from eravacycline treated and control strains of A.
Zhaoliang Su (396851)   +6 more
core   +1 more source

In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017

open access: yes, 2020
Eravacycline is a novel, fully synthetic fluorocycline antibiotic developed for the treatment of serious infections, including those caused by multidrug-resistant (MDR) pathogens.
Karlowsky, James A   +7 more
core   +1 more source

In vitro activity of omadacycline and eravacycline against Nocardia brasiliensis isolates

open access: yesFrontiers in Tropical Diseases
Actinomycetoma is a chronic, debilitating, neglected tropical disease primarily caused by Nocardia brasiliensis in Mexico and Central America. Current therapeutic standards involving high-dose trimethoprim–sulfamethoxazole are often complicated by ...
Hassiel Aurelio Ramírez-Marín   +2 more
doaj   +1 more source

Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial: A Randomized Clinical Trial

open access: yes, 2017
Importance: Eravacycline is a novel, fully synthetic fluorocycline antibiotic of the tetracycline class with in vitro activity against clinically important gram-negative, gram-positive aerobic, and facultative bacteria including most of those resistant ...
Lee, Patrick, MD
core  

Screening and comparison of in vitro-induced resistant and clinically resistant Stenotrophomonas maltophilia strains for eravacycline resistance-related genes

open access: yesFrontiers in Cellular and Infection Microbiology
ObjectiveTo identify genes related to eravacycline resistance in Stenotrophomonas maltophilia (Sm) and to provide a theoretical basis for the study of eravacycline resistance mechanisms in Sm and the development of new antibiotics.MethodsThe study ...
Jie Wu, Jiarong Song, Junchang Cui
doaj   +1 more source

Home - About - Disclaimer - Privacy